Elixinol Wellness Limited
ELLXF
$0.01
$0.0092.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.30% | 14.98% | 34.86% | 53.81% | 80.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.29% | 15.06% | 35.05% | 53.92% | 80.06% |
| Cost of Revenue | -0.40% | 13.50% | 33.35% | 56.54% | 91.24% |
| Gross Profit | 4.32% | 17.89% | 38.21% | 49.42% | 62.98% |
| SG&A Expenses | 8.72% | 6.59% | 5.88% | 0.13% | -5.43% |
| Depreciation & Amortization | -18.71% | -4.06% | 15.18% | 39.10% | 73.58% |
| Other Operating Expenses | -87.12% | 76.74% | 961.39% | 304.03% | 198.87% |
| Total Operating Expenses | 0.31% | 10.10% | 23.39% | 30.55% | 38.92% |
| Operating Income | 2.59% | 2.34% | 1.02% | 9.42% | 17.14% |
| Income Before Tax | -11.02% | 6.32% | 18.86% | 24.50% | 29.64% |
| Income Tax Expenses | 85.22% | -11.89% | -197,800.00% | -148,356.25% | -118,690.00% |
| Earnings from Continuing Operations | -212.83% | 14.11% | 71.61% | 74.72% | 77.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -212.83% | 14.11% | 71.61% | 74.72% | 77.29% |
| EBIT | 2.59% | 2.34% | 1.02% | 9.42% | 17.14% |
| EBITDA | 5.01% | 0.98% | -3.98% | 9.68% | 21.43% |
| EPS Basic | -31.19% | 68.28% | 89.82% | 88.41% | 87.54% |
| Normalized Basic EPS | 34.48% | 46.19% | 52.42% | 62.25% | 67.71% |
| EPS Diluted | -31.19% | 68.39% | 89.86% | 88.44% | 87.57% |
| Normalized Diluted EPS | 34.48% | 46.19% | 52.42% | 62.25% | 67.71% |
| Average Basic Shares Outstanding | 65.77% | 81.14% | 105.12% | 126.00% | 160.95% |
| Average Diluted Shares Outstanding | 65.77% | 81.14% | 105.12% | 126.00% | 160.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |